Abstract
Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) is a controversial practice permitted only in the United States and New Zealand. Central to why all other nations ban DTCA is concern about its capacity to impart complete, balanced, and accurate information that guides effective consumer decisions. Yet the debate has, thus far, paid scant attention to how implicit or unconscious persuasion in DTCA might influence consumer attitudes toward advertised drugs. In this chapter, one means of implicit persuasion, evaluative conditioning, is argued to have deleterious effects on the autonomous agency that DTCA viewers bring to medicine choices and on the wider doctor-patient relationship. These effects suggest implicit persuasion should be given much greater consideration in the development of public policy on the marketing of pharmaceuticals.
| Language | English |
|---|---|
| Title of host publication | Handbook of Neuroethics |
| Editors | Jens Clausen, Neil Levy |
| Place of Publication | Dordrecht |
| Publisher | Springer, Springer Nature |
| Pages | 1647-1668 |
| Number of pages | 22 |
| ISBN (Electronic) | 9789400747074 |
| ISBN (Print) | 9789400747067 |
| DOIs | |
| Publication status | Published - 1 Jan 2015 |
Fingerprint
Cite this
}
Ethics of implicit persuasion in pharmaceutical advertising. / Biegler, Paul; Kennett, Jeanette; Oakley, Justin; Vargas, Patrick.
Handbook of Neuroethics. ed. / Jens Clausen; Neil Levy. Dordrecht : Springer, Springer Nature, 2015. p. 1647-1668.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Research › peer-review
TY - CHAP
T1 - Ethics of implicit persuasion in pharmaceutical advertising
AU - Biegler, Paul
AU - Kennett, Jeanette
AU - Oakley, Justin
AU - Vargas, Patrick
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) is a controversial practice permitted only in the United States and New Zealand. Central to why all other nations ban DTCA is concern about its capacity to impart complete, balanced, and accurate information that guides effective consumer decisions. Yet the debate has, thus far, paid scant attention to how implicit or unconscious persuasion in DTCA might influence consumer attitudes toward advertised drugs. In this chapter, one means of implicit persuasion, evaluative conditioning, is argued to have deleterious effects on the autonomous agency that DTCA viewers bring to medicine choices and on the wider doctor-patient relationship. These effects suggest implicit persuasion should be given much greater consideration in the development of public policy on the marketing of pharmaceuticals.
AB - Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) is a controversial practice permitted only in the United States and New Zealand. Central to why all other nations ban DTCA is concern about its capacity to impart complete, balanced, and accurate information that guides effective consumer decisions. Yet the debate has, thus far, paid scant attention to how implicit or unconscious persuasion in DTCA might influence consumer attitudes toward advertised drugs. In this chapter, one means of implicit persuasion, evaluative conditioning, is argued to have deleterious effects on the autonomous agency that DTCA viewers bring to medicine choices and on the wider doctor-patient relationship. These effects suggest implicit persuasion should be given much greater consideration in the development of public policy on the marketing of pharmaceuticals.
UR - http://www.scopus.com/inward/record.url?scp=84929915738&partnerID=8YFLogxK
U2 - 10.1007/978-94-007-4707-4_1
DO - 10.1007/978-94-007-4707-4_1
M3 - Chapter
SN - 9789400747067
SP - 1647
EP - 1668
BT - Handbook of Neuroethics
A2 - Clausen, Jens
A2 - Levy, Neil
PB - Springer, Springer Nature
CY - Dordrecht
ER -